Trouble viewing this email? View it in your browser

Vol. 5

JUNE 2022

Issue 6.1

            Research news, updates & more from the Arthritis National Research Foundation



Betty Diamond, M.D., an ANRF Scientific Advisory Board (SAB) Member, was recently elected to the National Academy of Sciences (NAS) in recognition of her meritorious career in molecular medicine and original research. Throughout her career she has studied the DNA-reactive B cells, autoantibodies and their origin and effect on the body, focusing on the impact these antibodies have on the brain and how they may contribute to changes in cognition or behavior in patients with lupus.

Dr. Diamond, the director of the Institute of Molecular Medicine at Feinstein Institutes, was elected by her peers for this honor and upon receiving the honor said. Always humble and sure to include her peers and those she has mentored, Dr. Diamond acknowledged others upon receiving this recognition:

“It is an honor to be elected to the National Academy of Sciences. It is a time to acknowledge the many trainees and collaborators whose work led to this honor,” said Dr. Diamond, head of the Center for Autoimmune, Musculoskeletal and Hematopoietic Diseases at The Feinstein Institutes. “Together, we will continue to produce knowledge to cure disease.”

In her affiliation with the ANRF and specifically the SAB, she has brought great insight to the organization and has mentored current and previous grant funded recipients who are making significant strides in their own careers.



On Monday, May 30th, as many were observing Memorial Day in the U.S., Heather Hart departed the tropical state of Florida, making her way to the frigid temperatures of Alaska and to what it seems like, at times, an insurmountable adventure. There, with a love for outdoors, adventure, a new passion for mountaineering and a purpose-driven journey, she is laser-focused on summiting Denali, the tallest peak in North America.

Hart, an orthopedic Physician Assistant at the Center for Bone and Joint Disease (CBDJ) in Hudson, Fla., has been in intense training for this highly skilled 16-21-day expedition that requires being in top physical condition, climbing skills, an unparalleled commitment and passion. It also requires motivation. Hart not only finds her motivation in having a goal, but also in the patients she works with daily and the fundraiser she established through the Arthritis National Research Foundation (ANRF).

“On a daily basis, I see people limited by their arthritis. One thing I recurrently hear from patients, that absolutely devastates me, is when they mentally feel they can run, bike, hike and be active, but physically their bodies are slowing them down or holding them back altogether due to their arthritis,” Hart said.


HRA Launches Inclusive Grantmaking Initiative

As a member organization of the Health Research Alliance (HRA) consortium, the Arthritis National Research Foundation is eager to align its emerging diversity, equity and inclusion initiatives with the Inclusive Grantmaking Initiative the HRA has announced.

“It is imperative the ANRF invest time, resources and energy into DEI initiatives,” said CEO Emily Boyd Stormoen. “We have been evaluating where there needs to be extra focus and where there are opportunities and know we have work to do. It is ideal timing that HRA is announcing such a significant initiative, with resources and strategies that will help us advance.”



The Amazonian fruit açai, which comes from a palm tree, continues to become more popular and prevalent because of its nutritional value, including compounds with potent anti-inflammatory and antioxidant properties. These açai berries have appetite suppression qualities, are rich in fiber and help the digestive system, allowing the body to process foods better and burn fat more efficiently. This makes it easier to maintain a healthy weight and avoid unnecessary excess pressure on joints.


It's true — May, the official Arthritis Awareness Month, has concluded. But awareness doesn't stop with the conclusion of a month. In fact, it remains more important than ever. There continues to be more than 58.5 million people, and 300,000 juveniles, living with arthritis in the U.S. — and that's only those living with arthritis, not including related autoimmune diseases. 

As we prepare to announce the next cohort of grant funded scientists — all who are working toward finding better treatments, therapies, diagnostic tools and even a path to a cure — our fundraising continues so that we are able to support research that will change millions of lives. We look forward to introducing the latest grant recipients soon and hope that you can support this critical research too.


Providing initial research funding to brilliant, investigative scientists with new ideas to cure arthritis and related autoimmune diseases.

S I L V E R   P A R T N E R S


B R O N Z E   P A R T N E R S


E D U C A T I O N A L   G R A N T   P A R T N E R S


F O L L O W  U S


Replies to this email cannot be read. To let us know a question or feedback regarding the Chronicle,             email
To ensure email delivery, please add to your address book.
© 2022 Arthritis National Research Foundation
19200 Von Karman Ave., Suite 350, Irvine, CA 92612

Unsubscribe or Manage Your Preferences